A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Type of Cancer
Leukemia

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.